Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled date : 2020 - 12 - 04 save search
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis
Published: 2020-05-12 (Crawled : 16:19) - globenewswire.com
HSDT | $4.88 -3.84% -4.0% 3.9K
|
Health Technology
|
| O: 82.12%
H: 9.82%
C: -16.02%
multiple sclerosis fda sclerosis treatment device pons designation
Helius Medical Technologies, Inc. Submits Request for FDA Clearance for PoNS™ Device; Reports Preliminary Financial Results for the Second Quarter and Six Months Ended June 30, 2020
Published: 2020-08-06 (Crawled : 16:19) - globenewswire.com
HSDT | $4.88 -3.84% -4.0% 3.9K
|
Health Technology
|
| O: -7.23%
H: 5.26%
C: 0.0%
fda clearance fda pons clearance
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis
Published: 2020-10-19 (Crawled : 16:19) - globenewswire.com
HSDT | $4.88 -3.84% -4.0% 3.9K
|
Health Technology
|
| O: 3.48%
H: 0.0%
C: -5.76%
multiple sclerosis fda sclerosis pons clearance
Pressure BioSciences Proposed Acquisition Partner Cannaworx, Inc. Announces December 2020 Launch Date for FDA Registered Immune Booster
Published: 2020-12-04 (Crawled : 15:00) - biospace.com/
PBIO | $0.245 88.01% 33K
|
Health Technology
|
| O: 0.92%
H: 25.0%
C: 13.64%
fda acquisition
BioCryst Announces FDA Approval of ORLADEYO, First Therapy to Prevent HAE Attacks in Adults
Published: 2020-12-04 (Crawled : 14:00) - biospace.com/
BCRX | News | $4.375 -0.79% -0.8% 4.2M
|
Health Technology
|
| O: 13.92%
H: 6.84%
C: 4.27%
therapy fda approval fda approval
BioCryst Announces FDA Approval of ORLADEYO, First Therapy to Prevent HAE Att...
Published: 2020-12-04 (Crawled : 14:00) - biospace.com/
BCRX | News | $4.375 -0.79% -0.8% 4.2M
|
Health Technology
|
| O: 13.92%
H: 6.84%
C: 4.27%
therapy fda approval fda approval
Spero Therapeutics Announces FDA Acceptance of IND Application for SPR720
Published: 2020-08-31 (Crawled : 12:07) - globenewswire.com
SPRO | $1.435 2.14% 2.09% 120K
|
Health Technology
|
| O: 4.76%
H: 2.5%
C: -1.27%
fda fda acceptance application therapeutics
BioCryst Announces FDA Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
Published: 2020-12-04 (Crawled : 02:00) - globenewswire.com
BCRX | News | $4.375 -0.79% -0.8% 4.2M
|
Health Technology
|
| O: 13.92%
H: 6.84%
C: 4.27%
therapy fda approval fda approval hereditary angioedema
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.